致癌性p53通过复制赋予可靶向增殖优势的DNA复制叉,在肺癌细胞中诱导有丝分裂错误。

Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage.

作者信息

Deb Swati Palit, Singh Shilpa, Gheghiani Lilia, Frum Rebecca, Grossman Steven, Windle Brad, Deb Sumitra

机构信息

Virginia Commonwealth University.

Dana Farber Cancer Institute.

出版信息

Res Sq. 2025 Aug 13:rs.3.rs-7303237. doi: 10.21203/rs.3.rs-7303237/v1.

Abstract

Oncogenic p53 mutations (Onc-p53) are frequent in lung and many other solid tumors often associated with chromosome aberrations. Why cells with Onc-p53 develop chromosomal aberrations and whether the abnormalities contribute to tumor growth remain elusive. Evidence in this communication demonstrate for the first time that replication stress induced by Onc-p53 triggers re-copying of DNA replication forks, which generates replication intermediates that cause persistent mitotic aberration and DNA segregation errors. Replication intermediates from re-copied replication forks induced by Onc-p53 activate ATM signaling, which stabilizes Onc-p53, reinforces its ability to upregulate replication factors for sustaining replication stress, thus generating a feedforward cycle accelerating tumor formation. In agreement with this observation our time lapse video microscopy show in real time that persistent mitotic aberration and DNA segregation errors induced by Onc-p53 confer selective growth advantage. Accordingly, human lung tumors with Onc-p53 show selection of cells with mitotic aberration during serial passages. Knock down of active replication forks reduces re-copied fork generation by Onc-p53 and specifically induces apoptotic death of lung cancer cells expressing Onc-p53 in xenograft lung tumors synergistically in cooperation with inhibitors of ATM activation, deselecting cells with Onc-p53 with mitotic errors. This communication reveals a novel mechanism which interconnects replication stress induced by Onc-p53 to its stabilization and ability to generate chromosomal aberration in lung cancer cells that both accelerate tumor growth and serve as a targetable therapeutic vulnerability. These findings will be extremely valuable for tumor-specific treatment of a high percentage of cancer patients with p53 mutation.

摘要

致癌性p53突变(Onc-p53)在肺癌和许多其他实体瘤中很常见,且常与染色体畸变相关。带有Onc-p53的细胞为何会发生染色体畸变,以及这些异常是否有助于肿瘤生长,目前仍不清楚。本通讯中的证据首次表明,Onc-p53诱导的复制应激会触发DNA复制叉的重新复制,从而产生导致持续性有丝分裂畸变和DNA分离错误的复制中间体。Onc-p53诱导的重新复制的复制叉产生的复制中间体激活了ATM信号通路,该信号通路使Onc-p53稳定,增强其上调复制因子以维持复制应激的能力,从而形成一个前馈循环,加速肿瘤形成。与这一观察结果一致,我们的延时视频显微镜实时显示,Onc-p53诱导的持续性有丝分裂畸变和DNA分离错误赋予了选择性生长优势。因此,带有Onc-p53的人肺癌在连续传代过程中显示出有丝分裂畸变细胞的选择。抑制活跃的复制叉可减少Onc-p53产生的重新复制的叉,并与ATM激活抑制剂协同作用,特异性地诱导异种移植肺肿瘤中表达Onc-p53的肺癌细胞凋亡死亡,从而淘汰带有有丝分裂错误的Onc-p53细胞。本通讯揭示了一种新机制,该机制将Onc-p53诱导的复制应激与其在肺癌细胞中的稳定化以及产生染色体畸变的能力联系起来,这两者都加速了肿瘤生长,并成为一个可靶向治疗的弱点。这些发现对于高比例p53突变癌症患者的肿瘤特异性治疗将具有极其重要的价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索